Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B viral RNA refers to the RNA molecules transcribed in infected hepatocytes from the covalently closed circular DNA (cccDNA) of hepatitis B virus. The most notable forms are the pregenomic RNA (pgRNA)—serving as the template for reverse transcription into viral DNA—and several messenger RNAs encoding viral proteins, including surface (HBsAg), core (HBcAg), polymerase, and HBx. The pgRNA contains highly structured elements such as the epsilon stem-loop, which acts as a signal for encapsidation and directly participates in the formation of new viral particles[2][3]. Post-transcriptional modifications of HBV RNA, such as N6-methyladenosine (m6A), regulate its stability, efficiency of packaging, and successful viral replication[2]. Therapeutic intervention can aim at disrupting pgRNA synthesis, stability, or function, making HBV RNA an important molecular target for antiviral research and clinical monitoring[1][2][4].
Inhibition of reverse transcription (prevents RNA-to-DNA conversion); Modulation of RNA methylation (e.g., m6A modification affecting encapsidation and stability)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B viral RNA (HBV RNA).